Negligible Impact of Mass Screening and Treatment on Mesoendemic Malaria Transmission at West Timor in Eastern Indonesia: A Cluster-Randomized Trial
Open Access
- 22 March 2018
- journal article
- research article
- Published by Oxford University Press (OUP) in Clinical Infectious Diseases
- Vol. 67 (9) , 1364-1372
Abstract
Mass screening and treatment (MST) aims to reduce malaria risk in communities by identifying and treating infected persons without regard to illness. A cluster-randomized trial evaluated malaria incidence with and without MST. Clusters were randomized to 3, 2, or no MST interventions: MST3, 6 clusters (156 households/670 individuals); MST2, 5 clusters (89 households/423 individuals); and MST0, 5 clusters (174 households/777 individuals). All clusters completed the study with 14 residents withdrawing. In a cohort of 324 schoolchildren (MST3, n = 124; MST2, n = 57; MST0, n = 143) negative by microscopy at enrollment, we evaluated the incidence density of malaria during 3 months of MST and 3 months following. The MST intervention involved community-wide expert malaria microscopic screening and standard therapy with dihydroartemisinin-piperaquine and primaquine for glucose-6 phosphate dehydrogenase–normal subjects. All blood examinations included polymerase chain reaction assays, which did not guide on-site treatment. The risk ratios for incidence density of microscopically patent malaria in MST3 or MST2 relative to that in MST0 clusters were 1.00 (95% confidence interval [CI], .53–1.91) and 1.22 (95% CI, .42–3.55), respectively. Similar results were obtained with molecular analysis and species-specific (P. falciparum and P. vivax) infections. Microscopically subpatent, untreated infections accounted for 72% of those infected. Two or 3 rounds of MST within 3 months did not impact the force of anopheline mosquito-borne infection in these communities. The high rate of untreated microscopically subpatent infections likely explains the observed poor impact. NCT01878357.Keywords
Funding Information
- Bill and Melinda Gates Foundation (45114)
This publication has 33 references indexed in Scilit:
- Performance of a High-Sensitivity Rapid Diagnostic Test for Plasmodium falciparum Malaria in Asymptomatic Individuals from Uganda and Myanmar and Naive Human Challenge InfectionsThe American Journal of Tropical Medicine and Hygiene, 2017
- A systematic review of sub-microscopic Plasmodium vivax infectionMalaria Journal, 2015
- Global database of matched Plasmodium falciparum and P. vivax incidence and prevalence records from 1985–2013Scientific Data, 2015
- Population-Wide Malaria Testing and Treatment with Rapid Diagnostic Tests and Artemether-Lumefantrine in Southern Zambia: A Community Randomized Step-Wedge Control Trial DesignThe American Journal of Tropical Medicine and Hygiene, 2015
- Systematic Review of Sub-microscopic P. vivax Infections: Prevalence and Determining FactorsPLOS Neglected Tropical Diseases, 2015
- Mass Screening and Treatment on the Basis of Results of a Plasmodium falciparum-Specific Rapid Diagnostic Test Did Not Reduce Malaria Incidence in ZanzibarThe Journal of Infectious Diseases, 2014
- Primaquine for preventing relapse in people with Plasmodium vivax malaria treated with chloroquineCochrane Database of Systematic Reviews, 2013
- Treatment of asymptomatic carriers with artemether-lumefantrine: an opportunity to reduce the burden of malaria?Malaria Journal, 2010
- The role of anti-malarial drugs in eliminating malariaMalaria Journal, 2008
- Rapid Diagnostic Tests for Malaria ParasitesClinical Microbiology Reviews, 2002